Showing 1 to 12 of 218 results
Turkey's Diabetes Prevalence: A 67% Surge in Two Decades
Turkey's diabetes prevalence has increased by 67% in 20 years, reaching 16.6% in 2022, nearly double the EU average, prompting calls for improved healthcare policies and public health initiatives.
Turkey's Diabetes Prevalence: A 67% Surge in Two Decades
Turkey's diabetes prevalence has increased by 67% in 20 years, reaching 16.6% in 2022, nearly double the EU average, prompting calls for improved healthcare policies and public health initiatives.
Progress
28% Bias Score
Ig Nobel Prize Winners Announced
The 2025 Ig Nobel Prizes, awarded for research that makes people laugh then think, recognized studies on Teflon diets, alcohol's effect on language skills, and cow camouflage, among other quirky topics.
Ig Nobel Prize Winners Announced
The 2025 Ig Nobel Prizes, awarded for research that makes people laugh then think, recognized studies on Teflon diets, alcohol's effect on language skills, and cow camouflage, among other quirky topics.
Progress
40% Bias Score
Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery
Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.
Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery
Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.
Progress
16% Bias Score
Orforglipron: A New Daily Pill for Weight Loss Shows Promising Results
A 72-week trial of 3,127 obese adults found that orforglipron, a new daily weight-loss pill, led to significant weight loss, with 18.4% of those on the highest dose losing 20% or more of their body weight.
Orforglipron: A New Daily Pill for Weight Loss Shows Promising Results
A 72-week trial of 3,127 obese adults found that orforglipron, a new daily weight-loss pill, led to significant weight loss, with 18.4% of those on the highest dose losing 20% or more of their body weight.
Progress
44% Bias Score
High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
Progress
20% Bias Score
Mexico Increases Tax on Sugary Drinks: A Health Measure or Revenue Generator?
Mexico, a world leader in soft drink consumption, increased its tax on sugary beverages in 2024, aiming to curb obesity and diabetes; however, the effectiveness of this measure as a health initiative versus a revenue-generating tool remains debated.
Mexico Increases Tax on Sugary Drinks: A Health Measure or Revenue Generator?
Mexico, a world leader in soft drink consumption, increased its tax on sugary beverages in 2024, aiming to curb obesity and diabetes; however, the effectiveness of this measure as a health initiative versus a revenue-generating tool remains debated.
Progress
24% Bias Score
GLP-1 Agonists: Mechanisms of Weight Loss and Altered Taste Perception
New studies reveal that GLP-1 receptor agonists, like semaglutide and tirzepatide, induce weight loss in people with obesity by reducing appetite, slowing gastric emptying, increasing satiety, and altering taste perception, leading to reduced consumption of unhealthy foods.
GLP-1 Agonists: Mechanisms of Weight Loss and Altered Taste Perception
New studies reveal that GLP-1 receptor agonists, like semaglutide and tirzepatide, induce weight loss in people with obesity by reducing appetite, slowing gastric emptying, increasing satiety, and altering taste perception, leading to reduced consumption of unhealthy foods.
Progress
20% Bias Score
Oral Medication Shows Significant Weight Loss in Obesity Treatment
A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.
Oral Medication Shows Significant Weight Loss in Obesity Treatment
A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.
Progress
44% Bias Score
Japanese Study Reveals Psychological Factors Impacting Weight-Loss Drug Efficacy
A Japanese study of 92 diabetic patients found that individuals who overeat in response to palatable food respond better to GLP-1 agonist drugs than those who overeat due to emotional reasons, highlighting the importance of psychological factors in weight loss.
Japanese Study Reveals Psychological Factors Impacting Weight-Loss Drug Efficacy
A Japanese study of 92 diabetic patients found that individuals who overeat in response to palatable food respond better to GLP-1 agonist drugs than those who overeat due to emotional reasons, highlighting the importance of psychological factors in weight loss.
Progress
20% Bias Score
Novel Polymer Trap Shows Promise Against Type 2 Diabetes and Fatty Liver Disease
Canadian researchers developed a biodegradable polymer that traps D-lactate, a gut bacteria byproduct linked to type 2 diabetes and fatty liver disease, in obese mice, improving blood sugar control and liver health without dietary changes.
Novel Polymer Trap Shows Promise Against Type 2 Diabetes and Fatty Liver Disease
Canadian researchers developed a biodegradable polymer that traps D-lactate, a gut bacteria byproduct linked to type 2 diabetes and fatty liver disease, in obese mice, improving blood sugar control and liver health without dietary changes.
Progress
24% Bias Score
Government's Weak Health Regulations Contradict Public Opinion and Promises
The UK government's approach to regulating businesses impacting public health is criticized for being weak, contradicting previous promises and public opinion, with 74% wanting health prioritized over business growth, necessitating stronger actions like minimum alcohol pricing and tobacco levies.
Government's Weak Health Regulations Contradict Public Opinion and Promises
The UK government's approach to regulating businesses impacting public health is criticized for being weak, contradicting previous promises and public opinion, with 74% wanting health prioritized over business growth, necessitating stronger actions like minimum alcohol pricing and tobacco levies.
Progress
40% Bias Score
Rising Temperatures in the US Correlate with Increased Sugar Consumption
A new study reveals a concerning link between rising temperatures in the United States and increased consumption of added sugar, particularly among low-income and less-educated populations, resulting in over 100 million pounds of extra sugar consumed annually.
Rising Temperatures in the US Correlate with Increased Sugar Consumption
A new study reveals a concerning link between rising temperatures in the United States and increased consumption of added sugar, particularly among low-income and less-educated populations, resulting in over 100 million pounds of extra sugar consumed annually.
Progress
36% Bias Score
Showing 1 to 12 of 218 results